65,138 Shares in Cardinal Health, Inc. $CAH Acquired by Nykredit A S

Key Points

• Nykredit A S acquired 65,138 Cardinal Health shares worth approximately $15.5 million during the second quarter. Institutional investors and hedge funds collectively own 87.17% of the company.
• Cardinal Health reported quarterly earnings of $2.91 per share, beating estimates of $2.42, while revenue rose 5.8% year over year to $63.67 billion. The company provided fiscal 2027 EPS guidance of $12.40–$12.60.
• Analysts maintain a “Moderate Buy” consensus with an average price target of $266.56, while Cardinal Health declared a quarterly dividend of $0.5158 per share, yielding about 0.9% annually.

Nykredit A S acquired a new stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 65,138 shares of the company's stock, valued at approximately $15,474,000.

Several other institutional investors have also added to or reduced their stakes in CAH. Parkside Financial Bank & Trust boosted its stake in Cardinal Health by 2.5% in the second quarter. Parkside Financial Bank & Trust now owns 1,793 shares of the company's stock valued at $426,000 after buying an additional 43 shares in the last quarter. HighTower Advisors LLC lifted its holdings in shares of Cardinal Health by 18.6% in the second quarter. HighTower Advisors LLC now owns 93,896 shares of the company's stock worth $22,306,000 after acquiring an additional 14,750 shares during the last quarter. CYBER HORNET ETFs LLC lifted its holdings in shares of Cardinal Health by 430.2% in the second quarter. CYBER HORNET ETFs LLC now owns 3,462 shares of the company's stock worth $822,000 after acquiring an additional 2,809 shares during the last quarter. Nilsine Partners LLC boosted its stake in shares of Cardinal Health by 437.7% in the 2nd quarter. Nilsine Partners LLC now owns 6,049 shares of the company's stock valued at $1,437,000 after purchasing an additional 4,924 shares in the last quarter. Finally, Saudi Central Bank grew its holdings in shares of Cardinal Health by 87.8% during the 2nd quarter. Saudi Central Bank now owns 16,472 shares of the company's stock valued at $3,913,000 after purchasing an additional 7,702 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

CAH stock opened at $224.95 on Friday. The company has a market capitalization of $52.32 billion, a P/E ratio of 31.11, a PEG ratio of 1.35 and a beta of 0.51. The company has a fifty day moving average price of $233.74 and a 200-day moving average price of $219.86. Cardinal Health, Inc. has a 52-week low of $145.87 and a 52-week high of $258.30.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, topping the consensus estimate of $2.42 by $0.49. The company had revenue of $63.67 billion for the quarter, compared to analysts' expectations of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. Cardinal Health's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, sell-side analysts forecast that Cardinal Health, Inc. will post 12.55 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be given a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Thursday, October 1st. Cardinal Health's dividend payout ratio (DPR) is 28.49%.

Wall Street Analyst Weigh In

CAH has been the subject of several research reports. Wall Street Zen downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday. JPMorgan Chase & Co. upped their price target on shares of Cardinal Health from $215.00 to $260.00 and gave the stock a "neutral" rating in a report on Thursday, August 13th. Royal Bank Of Canada began coverage on Cardinal Health in a research note on Wednesday, August 19th. They issued an "outperform" rating and a $276.00 price target for the company. TD Cowen boosted their price objective on Cardinal Health from $275.00 to $280.00 and gave the stock a "buy" rating in a research report on Thursday, August 13th. Finally, Bank of America upped their target price on Cardinal Health from $240.00 to $260.00 and gave the stock a "buy" rating in a report on Thursday, July 2nd. Sixteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Cardinal Health has a consensus rating of "Moderate Buy" and an average price target of $266.56.

Insider Buying and Selling

In related news, insider Jessica Mayer sold 29,436 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $236.19, for a total value of $6,952,488.84. Following the transaction, the insider directly owned 33,076 shares of the company's stock, valued at $7,812,220.44. The trade was a 47.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Stephen Mason sold 35,000 shares of the stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $236.40, for a total transaction of $8,274,000.00. Following the sale, the chief executive officer directly owned 18,061 shares of the company's stock, valued at $4,269,620.40. This represents a 65.96% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 210,271 shares of company stock valued at $49,626,657 over the last 90 days. 0.12% of the stock is currently owned by corporate insiders.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company that supports the pharmaceutical and medical industries. Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, over-the-counter products and consumer health items to pharmacies, hospitals, health systems and other healthcare providers. The segment also provides specialty pharmaceutical services, nuclear and radiopharmaceutical products, and related support for manufacturers and providers.

Through its Global Medical Products and Distribution segment, Cardinal Health manufactures, sources and distributes medical and surgical products, including gloves, gowns, syringes, exam-room supplies and other essential equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.